How many sats is one Bristol Myers Squibb share?

68,161 sats ($56.67) at the close on October 13, 2026, or 0.00068 bitcoin.

Has Bristol Myers Squibb beaten bitcoin?

Measured by share price, no: a share costs 91% fewer sats than its 2019 average (in dollars: +13%). Measured by the business (cash generated per share and its growth), −21% a year in bitcoin terms, behind bitcoin's supply growth.

Did Bristol Myers Squibb's buybacks beat bitcoin?

No. It spent $28.3 billion buying back its own stock since 2019. Each $1 is now worth $0.91 in shares; the same $1 in bitcoin, bought at the same times, would be worth $4.61. (Per dollar: at that size the buying itself would have moved bitcoin's price.)

Sats Ledger

Companies · Health care

Bristol Myers Squibb (BMY), measured in bitcoin

One Bristol Myers Squibb share costs 68,161 sats today ($56.67). That's 81% more sats than a year ago, so over the past year the stock beat holding bitcoin. Since 2019, its shareholder return has been +13% a year in dollars, faster than the money supply grew (+6.6%), and −21% a year measured in bitcoin.

Next earnings: Thursday, October 29 before the open.

Price in sats

68,161

What one share costs in bitcoin today ($56.67). One bitcoin is 100 million sats.

Past year, in bitcoin

+81% +30% in $

More sats per share than a year ago. Above zero means the stock beat simply holding bitcoin.

Shareholder return since COVID

+13%/yr −21%/yr in ₿

Cash the business produces per share, plus how fast that grows, since 2019. Beat new dollars (+6.6%/yr); trailed bitcoin (+1.8%/yr new supply).

Buybacks vs bitcoin

$0.91 vs $4.61

What each $1 it spent buying back its own stock since 2019 is worth today, versus the same $1 in bitcoin bought at the same times. Bitcoin wins.

Quarterly revenue would buy

0.86% of all bitcoin

$13.0 billion of revenue in the quarter to Jun 30, 2026, at that quarter's average price: ₿181,107 of the 21 million that will ever exist.

Pays its own way?

Yes

Since mid-2022 it kept $20.7 billion of free cash flow after dividends and buybacks.

Bristol Myers Squibb share price since 2019, in dollars and in bitcoin, both indexed to 100 — Both lines start at 100 (the 2019 average). The gap between them is what measuring in bitcoin changes.

How it compares: health care

Sorted by the past year in bitcoin. Within the same window every stock is divided by the same bitcoin price, so the order matches dollars; what bitcoin adds is the line at zero: above it, the stock beat holding bitcoin.

Company	Sats per share	Past year, ₿	Vs 2019 avg, ₿	Shareholder return, ₿
Merck MRK	170,769	+130%	−86%	−22%/yr
Lilly LLY	1,403,043	+97%	−25%	–
Amgen AMGN	496,552	+96%	−84%	−24%/yr
Johnson & Johnson JNJ	299,021	+81%	−86%	−26%/yr
Bristol Myers Squibb BMY	68,161	+81%	−91%	−21%/yr
Thermo Fisher Scientific TMO	797,485	+75%	−82%	−22%/yr
Gilead Sciences GILD	177,914	+74%	−83%	−20%/yr
AbbVie ABBV	329,992	+65%	−74%	−26%/yr
Pfizer PFE	34,123	+59%	−95%	−26%/yr
CVS Health CVS	105,303	+55%	−89%	−19%/yr
Danaher DHR	268,025	+51%	−85%	−23%/yr
UnitedHealth UNH	454,358	+46%	−89%	−19%/yr
Medtronic MDT	111,870	+35%	−93%	−24%/yr
Intuitive Surgical ISRG	507,641	+34%	−82%	−18%/yr
Abbott Laboratories ABT	123,416	+8.3%	−90%	−21%/yr

Questions

How many sats is one Bristol Myers Squibb share?: 68,161 sats ($56.67) at the close on October 13, 2026, or 0.00068 bitcoin.
Has Bristol Myers Squibb beaten bitcoin?: Measured by share price, no: a share costs 91% fewer sats than its 2019 average (in dollars: +13%). Measured by the business (cash generated per share and its growth), −21% a year in bitcoin terms, behind bitcoin's supply growth.
Did Bristol Myers Squibb's buybacks beat bitcoin?: No. It spent $28.3 billion buying back its own stock since 2019. Each $1 is now worth $0.91 in shares; the same $1 in bitcoin, bought at the same times, would be worth $4.61. (Per dollar: at that size the buying itself would have moved bitcoin's price.)

Full history, charts and quarterly numbers for Bristol Myers Squibb →